Article · 30 Dec 2024
Conference abstractPublished 15 Jul 2013
Biomarker-driven Drug Development
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Biomarkers play important roles in drug development to confirm target engagement of drug candidates, to determine right dose, to select right patients and to supply right medication. Pharmacodynamics (PD) is the study of the biochemical and physiological effects of drugs on the body by interacting drugs with the target molecules. PD is deeply related with mode-of- action of drug candidates, therefore PD biomarkers can achieve proof-of-mechanism (POM). Recent progress of disease etiology has provided sub-category of the disease. It is now highly important to identify right patient population among several disease sub-categories to increase response rate of the drug candidates and reduce number of subjects in phase II and /or phase III studies. Patient stratification is expected to increase the success rate and accelerate product creation, and leads patients toward personalized medicine era. To determine ?right patients?, we need to enhance the technology platform and covert biomarkers to diagnostics. Response/efficacy markers, which can be detected in early clinical study to increase confidence of projects, and exclude poor-response patients from clinical trials at earlier time points, which is useful to avoid unnecessary adverse effects on poor-responders. Efficacy biomarkers can also encourage patients to continue taking right medicine. Therefore, using the response markers brings a benefit to patients as ?right medication?. Biomarkers are also keys to diagnose disease and monitor disease situation. Several biomarker examples will be discussed
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 26 Jun 2024
Biomarker-Driven Trials: Transforming Clinical Research and Personalized Medicine
Short communication · 28 Aug 2024
Leveraging Molecular Biomarkers to Accelerate Drug Development and Optimize Treatments
Mini review · 11 Jun 2024
The Role of Molecular Biomarkers in Enhancing Drug Development and Treatment
Mini review · 29 Apr 2024
The Integration of Molecular Biomarkers in Drug Development and Therapeutics
More from this journal
The newest in Journal of Molecular Biomarkers & Diagnosis.
Brief report · 29 Dec 2025
Biomarker Discovery To Clinical Translation: A Holistic Approach
Commentary · 29 Dec 2025
Molecular Diagnostics: Revolutionizing Precision Healthcare
Commentary · 29 Dec 2025
Genomic Biomarkers Revolutionizing Disease Diagnosis and Medicine
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Molecular Biomarkers & Diagnosis
- SubjectGenetics & Molecular Biology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Yoshiya Oda”

